Changing the policy for intermittent preventive treatment with sulfadoxine–pyrimethamine during pregnancy in Malawi

by Chikondi A. Mwendera, Christiaan de Jager, Herbert Longwe et al.
Malaria Journal, 2017 16:84 – Published: 20 February 2017

13 pp. 1.2 MB
http://malariajournal.biomedcentral.com/track/pdf/10.1186/s12936-017-1736-9?
site=malariajournal.biomedcentral.com

The growing resistance of Plasmodium falciparum to sulfadoxine–pyrimethamine (SP) treatment for uncomplicated malaria led to a recommendation by the World Health Organization for the use of artemisinin-based combination therapy. Inevitably, concerns were also raised surrounding the use of SP for intermittent prevention treatment of malaria during pregnancy (IPTp) amidst the lack of alternative drugs. Malawi was the first country to adopt intermittent prevention treatment with SP in 1993, and updated in 2013. This case study examines the policy updating process and the contribution of research and key stakeholders to this process. The findings support the development of a malaria research-to-policy framework in Malawi.

(Visited 13 times, 1 visits today)
This entry was posted in Essential Medicines, General, Malaria, Maternal & Child Health. Bookmark the permalink.